Eco-friendly synthesis of ZnO, CuO, and ZnO/CuO nanoparticles using extract of spent Pleurotus ostreatus substrate, and their antioxidant and anticancer activities.

Metadata-grounded summary

Citation abstract

Biosynthesis techniques for nanomaterials have advanced significantly, promoting eco-friendly synthesis chemistry as a sustainable alternative to conventional methods. This study presents a novel and environmentally friendly approach for synthesizing nanoparticulate ZnO, CuO, and ZnO/CuO nanocomposites using aqueous extracts of Pleurotus ostreatus spent substrate, is reported. The structural, optical, and morphological properties of the synthesized NPs were analysed. A hexagonal phase of ZnO NPs and a monoclinic phase of CuO NPs were obtained according to the X-ray diffraction analysis. A reduction in the peak intensity of these metal oxides was observed in the ZnO/CuO NPs due to reduced crystallinity. The absorption spectra, obtained from the UV-vis analysis, showed peaks at 354, 365, and 525 nm for the ZnO, CuO, and ZnO/CuO NPs, respectively. An anticancer assay of the NPs was conducted using human embryonic kidney (HEK 293) and cervical carcinoma (HeLa) cell lines, while a 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was used for the antioxidant evaluation. The ZnO, CuO, and ZnO/CuO NPs showed higher antioxidant potency with IC 50 of 2.15, 2.16, and 3.18 µg/mL, respectively, than the ascorbic acid (4.25 µg/mL). This indicates that the nanoparticles were more effective in capturing DPPH free radicals. Anticancer assays showed strong cytotoxic effects for all nanoparticles, with ZnO NPs exhibiting the highest activity (IC 50: 1.94 μM for HEK 293 cells, 3.23 μM for HeLa cells), surpassing CuO and ZnO/CuO NPs. Cell viability for both HEK 293 and HeLa cells decreased as nanoparticle concentration increased, confirming dose-dependent cytotoxicity. The green synthesized metal oxides and their composite have the potential for biomedical applications.